News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer

In an international phase 3 trial, researchers find S-1 (a contemporary oral fluoropyrimidine)/ cisplatin and 5-fluorouracil (5-FU)/cisplatin are similar in efficacy and safety in patients with advanced stomach cancer.

Read Source